<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Savient Pharmaceuticals Inc. | Company News & Executive Profiles - SVNT | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/savient+pharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Savient Pharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="10" found="25" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Once Again, Savient Disappoints Investors]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F153542-once-again-savient-disappoints-investors%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[EP Vantage submits: Savient SVNT once again demonstrated its ability to disappoint investors, yesterday announcing that the FDA has refused to grant its new gout treatment, Krystexxa, a marketing license. The news prompted shares in the company to plunge 30% in early trade. Even though no further trials have been...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 04 Aug 2009 03:57:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/ep+vantage.html"><![CDATA[EP Vantage]]></category>
		<category domain="http://resources.bnet.com/topic/savient+pharmaceuticals+inc..html"><![CDATA[Savient Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SVNT</category>
		<category domain="tickers">SVNT</category>
	</item>
	<item>
		<title><![CDATA[Savient's Nasty Gout Surprise]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F153323-savient-s-nasty-gout-surprise%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Derek Lowe submits:  Well, here's a nasty surprise for you: your new drug gets a 14 to 1 "Yes" vote from an FDA advisory committee, but the agency turns you down, anyway. That's what's just happened to Savient SVNT and their new biologic product for gout, Krystexxa pegloticase. ...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Mon, 03 Aug 2009 07:18:06 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/derek+lowe.html"><![CDATA[Derek Lowe]]></category>
		<category domain="http://resources.bnet.com/topic/savient+pharmaceuticals+inc..html"><![CDATA[Savient Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SVNT</category>
		<category domain="tickers">SVNT</category>
	</item>
	<item>
		<title><![CDATA[Savient Up Big on Friday]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F142976-savient-up-big-on-friday%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Ockham Research submits:  Savient Pharmaceuticals SVNT is trading about 60% higher in afternoon trading on Friday, and the circumstances surrounding the massive gains a bit perplexing.  Savient, a specialty biopharmaceuticals company, has a drug called Krystexxa that is used to treat gout patients.  This drug has been...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 12 Jun 2009 01:38:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/ockham+research.html"><![CDATA[Ockham Research]]></category>
		<category domain="http://resources.bnet.com/topic/savient+pharmaceuticals+inc..html"><![CDATA[Savient Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SVNT</category>
		<category domain="tickers">SVNT</category>
	</item>
	<item>
		<title><![CDATA[Savient Pharmaceuticals, Inc. Q1 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-300216.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions We will go to Eric Schmidt with Cowen & Company. Eric Schmidt &#8211; Cowen & Company Well thanks for taking my call. Just on the prelaunch activities, when would you estimate, something you've got to favorable recommendation of the panel and approval on August 1,...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 08 May 2009 05:48:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/advisory+committee.html"><![CDATA[Advisory Committee]]></category>
		<category domain="http://resources.bnet.com/topic/eric+schmidt.html"><![CDATA[Eric Schmidt]]></category>
		<category domain="http://resources.bnet.com/topic/cowen+%2526+co..html"><![CDATA[Cowen & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/savient+pharmaceuticals+inc..html"><![CDATA[Savient Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SVNT</category>
		<category domain="tickers">SVNT</category>
	</item>
	<item>
		<title><![CDATA[Savient Pharmaceuticals, Inc, Q4 Year Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-273364.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator instructions  And we'll go first to Eric Varma with Leerwink Swann.  Eric Varma &#8211; Leerwink Swann Hey, good morning I had a quick question on a follow-on about febuxostat.  If you can just kind of remind us how the CV incidents compare between...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 26 Feb 2009 12:31:13 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/trial.html"><![CDATA[Trial]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[Therapy]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/savient+pharmaceuticals+inc..html"><![CDATA[Savient Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SVNT</category>
		<category domain="tickers">SVNT</category>
	</item>
	<item>
		<title><![CDATA[Two Near-Term Biotech Plays]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F112743-two-near-term-biotech-plays%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[David White submits: The news wire yesterday (December 30, 2008) reported that two drug companies have been granted priority review status for their new submittals: Northfield Laboratories NFLD and Savient Pharmaceticals SVNT. Naturally both of these stocks shot up yesterday. However, it will take time for the news to filter...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 31 Dec 2008 01:43:28 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/david+white.html"><![CDATA[David White]]></category>
		<category domain="http://resources.bnet.com/topic/northfield+laboratories+inc..html"><![CDATA[Northfield Laboratories Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/savient+pharmaceuticals+inc..html"><![CDATA[Savient Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NFLD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SVNT</category>
		<category domain="tickers">NFLD,SVNT</category>
	</item>
	<item>
		<title><![CDATA[Earnings Preview: Savient Pharmaceuticals]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F104164-earnings-preview-savient-pharmaceuticals%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Savient Pharmaceuticals SVNT is expected to report Q3 earnings after market close Wednesday Nov. 5,  with a conference call scheduled for Thursday, November 6 at 10:00 am ET. Guidance Analysts are expecting a loss of (39c) on revenue of $600K. The consensus range for EPS is (42c) to (35c) with...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 05 Nov 2008 08:23:39 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/revenue.html"><![CDATA[Revenue]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/theflyonthewall.com.html"><![CDATA[theflyonthewall.com]]></category>
		<category domain="http://resources.bnet.com/topic/savient+pharmaceuticals+inc..html"><![CDATA[Savient Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SVNT</category>
		<category domain="tickers">SVNT</category>
	</item>
	<item>
		<title><![CDATA[Tuesday Options Outlook: LEH, WM, AIG, OIH, DOX, TRA, SVNT]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F94650-tuesday-options-outlook-leh-wm-aig-oih-dox-tra-svnt%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Rebecca Engmann Darst co-authored this article. Lehman Brothers LEH &#8211; Traders lost patience with still-fruitless talks between Lehman Brothers and Korea Development Bank, and a concomitant increase in the price of credit default protection appeared to be all it took to send implied volatility up some 88% as shares tanked...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 09 Sep 2008 10:11:36 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/american+international+group+inc..html"><![CDATA[American International Group Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/us+market.html"><![CDATA[US Market]]></category>
		<category domain="http://resources.bnet.com/topic/amdocs.html"><![CDATA[Amdocs]]></category>
		<category domain="http://resources.bnet.com/topic/lehman+brothers+holdings+inc..html"><![CDATA[Lehman Brothers Holdings Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/savient+pharmaceuticals+inc..html"><![CDATA[Savient Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/terra+industries+inc..html"><![CDATA[Terra Industries Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/washington+mutual+inc..html"><![CDATA[Washington Mutual Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DOX</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AIG</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">LEH</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SVNT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">TRA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">WM</category>
		<category domain="tickers">DOX,AIG,LEH,SVNT,TRA,WM</category>
	</item>
	<item>
		<title><![CDATA[Savient Pharmaceuticals, Inc. Q2 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-224412.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator [Operator instructions]. And your first question is from Leland Gershell from Cowen and Company.  Leland Gershell Hi, good morning. Thanks for taking my questions. With those seven patients treated with a dose in the re-exposure trial, any safety observations you can share with us from those...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 07 Aug 2008 12:53:16 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/savient+pharmaceuticals+inc..html"><![CDATA[Savient Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SVNT</category>
		<category domain="tickers">SVNT</category>
	</item>
	<item>
		<title><![CDATA[Savient Pharmaceuticals, Inc. Q4 2007 Earning Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-229225.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions.  Your first question will come from the line of Leland Gershell with Cowen & Company. Leland Gershell Good morning.  Thanks for the update and for taking my questions.  I was wondering, first question you had mentioned previously the intention to conduct re-treatment...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 12 Mar 2008 14:55:11 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/savient+pharmaceuticals+inc..html"><![CDATA[Savient Pharmaceuticals Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">SVNT</category>
		<category domain="tickers">SVNT</category>
	</item>
</channel>
</rss>
